Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Roche describes new Toll-like receptor 7/8/9 antagonists

Dec. 20, 2019

European Commission approves Rinvoq for rheumatoid arthritis

Dec. 19, 2019

Cantargia announces start of CAN-10 development project for systemic sclerosis and myocarditis

Dec. 10, 2019

Biogen reports phase II data from LILAC study of BIIB-059

Dec. 4, 2019

Impaired ATM function linked to worse rheumatoid arthritis

Dec. 4, 2019

Subcutaneous infliximab biosimilar approved in the E.U. for the treatment of RA

Nov. 28, 2019

Lipids and lupus

Nov. 27, 2019

Upadacitinib demonstrates promising safety and efficacy in phase II/III SELECT-AXIS 1 study

Nov. 25, 2019

Osteoclast precursor macrophages are potential RA therapeutic targets

Nov. 22, 2019

AbbVie constructs anti-TNF-alpha antibody-steroid antibody-drug conjugate for rheumatoid arthritis

Nov. 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...